Intravenous Artesunate for Severe Malaria in Travelers, Europe

Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe mala...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zoller, Thomas, Junghanss, Thomas, Kapaun, Annette, Gjørup, Ida, Richter, Joachim, Hugo-Persson, Mats, Mørch, Kristine, Foroutan, Behruz, Suttorp, Norbert, Yürek, Salih, Flick, Holger
Format: Artigo
Langue:Inglês
Publié: Centers for Disease Control and Prevention 2011
Sujets:
Synopsis
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321768/
https://ncbi.nlm.nih.gov/pubmed/21529383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid1705.101229
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires